Skip to Content

'
Jennifer Litton, MD

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Research Interests

Pregnancy and breast cancer.

Genetic testing.

Molecular changes of breast cancer genes.

Education & Training

Degree-Granting Education

2000 University of Massachusetts Medical School, Worcester, MA, MD, Medicine
1992 Duke University, Durham, NC, AB, History and English

Postgraduate Training

12/2004-12/2006 Clinical Fellowship, The University of Texas M. D. Anderson Cancer Center, Houston, TX
7/2003-6/2004 Chief Resident, Baylor College of Medicine, Houston, TX
7/2001-6/2003 Clinical Residency, Baylor College of Medicine, Houston, TX
6/2000-6/2001 Clinical Internship, Baylor College of Medicine, Houston, TX

Board Certifications

11/2007 Medical Oncology
8/2003 ABIM

Experience/Service

Other Appointments/Responsibilities

Guideline Panel Member Genetic/Familial High Risk Assessment: Breast and Ovarian Panel, National Comprehensive Cancer Network, Fort Washington, PA, 1/2008-present

Institutional Committee Activities

Member, Clinical Research Committee 3, 2007-present

Selected Publications

Peer-Reviewed Original Research Articles
1. Litton JK, Westin SN, Ready K, Sun CC, Peterson SK, Meric-Bernstam F, Gonzalez-Angulo AM, Bodurka DC, Lu KH, Hortobagyi GN, Arun BK. Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation. Cancer 115(8):1598-1604, 3/11/2009. e-Pub 3/11/2009. PMID: 19280625.
2. Beadle BM, Woodward WA, Middleton LP, Tereffe W, Strom EA, Litton JK, Meric-Bernstam F, Theriault RL, Buchholz TA, Perkins GH. The impact of pregnancy on breast cancer outcomes in women </=35 years. Cancer 115(6):1174-84, 2/2009. e-Pub 2/2009. PMID: 19204903.
3. Litton JK, Gonzalez-Angulo AM, Warneke C, Buzdar AU, Kau S, Bondy M, Mahabir S, Hortobagyi GN, Brewster AM. The relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol 27(5):829-30, 2/2009. PMID: 18757321.
4. Eralp Y, Smith TL, Altundag K, Kau SW, Litton J, Valero V, Buzdar A, Hortobagyi GN, Arun B. Clinical features associated with a favorable outcome following neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or younger. J Cancer Res Clin Oncol 135(1):141-8, 1/2009. e-Pub 6/2008. PMID: 18581139.
5. Beadle BM, Woodward WA, Tucker SL, Outlaw ED, Allen PK, Oh JL, Strom EA, Perkins GH, Tereffe W, Yu TK, Meric-Bernstam F, Litton JK, Buchholz TA. Ten-Year Recurrence Rates in Young Women With Breast Cancer by Locoregional Treatment Approach. Int J Radiat Oncol Biol Phys 73(3):734-44, 8/2008. e-Pub 8/15/2008. PMID: 18707822.
6. Litton JK, Eralp Y, Gonzalez-Angulo AM, Broglio K, Uyei A, Hortobagyi GN, Arun B. Multifocal breast cancer in women < or =35 years old. Cancer 110(7):1445-50, 10/2007. PMID: 17676585.
7. Shapiro CL, Ervin T, Welles L, Azarnia N, Keating J, Hayes DF. Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer. TLC D-99 Study Group. J Clin Oncol 17(5):1435-41, 5/1999. PMID: 10334528.
8. Shapiro CL, Keating J, Angell JE, Janicek M, Gelman R, Hayes D, LeBoff MS. Monitoring therapeutic response in skeletal metastases using dual-energy X-ray absorptiometry: a prospective feasibility study in breast cancer patients. Cancer Invest 17(8)(8):566-74, 1999. PMID: 10592763.
9. Shapiro CL, Ayash L, Webb I, Gelman R, Keating J, Williams L, Demetri G, Clark P, Elias A, Duggan D, Hayes D, Hurd D, Henderson IC. Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral blood progenitor cells and filgrastim in advanced breast cancer patients. J Clin Oncol 15(2)::674-83, 1997.

Last updated: 9/22/2009